Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 21 |
NetGPI | no | yes: 0, no: 21 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: E9B3W0
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0016740 | transferase activity | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 161 | 165 | PF00656 | 0.551 |
CLV_C14_Caspase3-7 | 168 | 172 | PF00656 | 0.785 |
CLV_PCSK_SKI1_1 | 154 | 158 | PF00082 | 0.419 |
CLV_PCSK_SKI1_1 | 34 | 38 | PF00082 | 0.332 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.659 |
DOC_CYCLIN_RxL_1 | 150 | 161 | PF00134 | 0.445 |
DOC_MAPK_DCC_7 | 295 | 303 | PF00069 | 0.346 |
DOC_MAPK_gen_1 | 180 | 189 | PF00069 | 0.406 |
DOC_MAPK_MEF2A_6 | 295 | 303 | PF00069 | 0.330 |
DOC_PP1_RVXF_1 | 32 | 39 | PF00149 | 0.513 |
DOC_PP2B_LxvP_1 | 83 | 86 | PF13499 | 0.380 |
DOC_USP7_MATH_1 | 3 | 7 | PF00917 | 0.603 |
DOC_WW_Pin1_4 | 174 | 179 | PF00397 | 0.727 |
DOC_WW_Pin1_4 | 253 | 258 | PF00397 | 0.431 |
DOC_WW_Pin1_4 | 303 | 308 | PF00397 | 0.443 |
LIG_14-3-3_CanoR_1 | 2 | 8 | PF00244 | 0.569 |
LIG_14-3-3_CanoR_1 | 323 | 329 | PF00244 | 0.632 |
LIG_14-3-3_CanoR_1 | 93 | 101 | PF00244 | 0.356 |
LIG_BIR_III_2 | 194 | 198 | PF00653 | 0.346 |
LIG_BRCT_BRCA1_1 | 93 | 97 | PF00533 | 0.502 |
LIG_Clathr_ClatBox_1 | 219 | 223 | PF01394 | 0.381 |
LIG_eIF4E_1 | 255 | 261 | PF01652 | 0.341 |
LIG_FHA_1 | 2 | 8 | PF00498 | 0.617 |
LIG_FHA_1 | 254 | 260 | PF00498 | 0.384 |
LIG_FHA_1 | 308 | 314 | PF00498 | 0.639 |
LIG_FHA_2 | 228 | 234 | PF00498 | 0.591 |
LIG_FHA_2 | 50 | 56 | PF00498 | 0.481 |
LIG_FHA_2 | 86 | 92 | PF00498 | 0.446 |
LIG_LIR_Gen_1 | 181 | 189 | PF02991 | 0.448 |
LIG_LIR_Nem_3 | 181 | 187 | PF02991 | 0.467 |
LIG_LIR_Nem_3 | 200 | 204 | PF02991 | 0.280 |
LIG_LIR_Nem_3 | 249 | 253 | PF02991 | 0.417 |
LIG_LIR_Nem_3 | 35 | 41 | PF02991 | 0.403 |
LIG_LIR_Nem_3 | 43 | 48 | PF02991 | 0.306 |
LIG_PAM2_1 | 275 | 287 | PF00658 | 0.311 |
LIG_SH2_CRK | 45 | 49 | PF00017 | 0.354 |
LIG_SH2_SRC | 240 | 243 | PF00017 | 0.343 |
LIG_SH2_STAT5 | 103 | 106 | PF00017 | 0.364 |
LIG_SH2_STAT5 | 116 | 119 | PF00017 | 0.370 |
LIG_SH2_STAT5 | 201 | 204 | PF00017 | 0.334 |
LIG_SH2_STAT5 | 240 | 243 | PF00017 | 0.355 |
LIG_SH2_STAT5 | 255 | 258 | PF00017 | 0.541 |
LIG_SH3_3 | 11 | 17 | PF00018 | 0.409 |
LIG_SH3_3 | 128 | 134 | PF00018 | 0.354 |
LIG_SH3_3 | 172 | 178 | PF00018 | 0.749 |
LIG_SH3_3 | 21 | 27 | PF00018 | 0.466 |
LIG_SH3_5 | 197 | 201 | PF00018 | 0.345 |
LIG_SUMO_SIM_par_1 | 185 | 190 | PF11976 | 0.415 |
LIG_SUMO_SIM_par_1 | 218 | 223 | PF11976 | 0.338 |
LIG_WRC_WIRS_1 | 247 | 252 | PF05994 | 0.332 |
MOD_CDC14_SPxK_1 | 177 | 180 | PF00782 | 0.520 |
MOD_CDK_SPxK_1 | 174 | 180 | PF00069 | 0.514 |
MOD_CK1_1 | 268 | 274 | PF00069 | 0.406 |
MOD_CK1_1 | 293 | 299 | PF00069 | 0.362 |
MOD_CK1_1 | 306 | 312 | PF00069 | 0.536 |
MOD_CK2_1 | 179 | 185 | PF00069 | 0.513 |
MOD_CK2_1 | 227 | 233 | PF00069 | 0.384 |
MOD_CK2_1 | 85 | 91 | PF00069 | 0.434 |
MOD_GlcNHglycan | 113 | 116 | PF01048 | 0.442 |
MOD_GlcNHglycan | 126 | 129 | PF01048 | 0.339 |
MOD_GlcNHglycan | 158 | 161 | PF01048 | 0.548 |
MOD_GlcNHglycan | 27 | 30 | PF01048 | 0.488 |
MOD_GlcNHglycan | 295 | 298 | PF01048 | 0.351 |
MOD_GSK3_1 | 174 | 181 | PF00069 | 0.647 |
MOD_GSK3_1 | 18 | 25 | PF00069 | 0.507 |
MOD_GSK3_1 | 303 | 310 | PF00069 | 0.559 |
MOD_GSK3_1 | 324 | 331 | PF00069 | 0.643 |
MOD_GSK3_1 | 44 | 51 | PF00069 | 0.353 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.564 |
MOD_NEK2_1 | 290 | 295 | PF00069 | 0.299 |
MOD_NEK2_1 | 314 | 319 | PF00069 | 0.643 |
MOD_NEK2_1 | 44 | 49 | PF00069 | 0.363 |
MOD_NEK2_1 | 97 | 102 | PF00069 | 0.373 |
MOD_NEK2_2 | 3 | 8 | PF00069 | 0.622 |
MOD_NEK2_2 | 65 | 70 | PF00069 | 0.476 |
MOD_PIKK_1 | 227 | 233 | PF00454 | 0.564 |
MOD_PIKK_1 | 324 | 330 | PF00454 | 0.667 |
MOD_PKA_2 | 1 | 7 | PF00069 | 0.597 |
MOD_PKA_2 | 179 | 185 | PF00069 | 0.466 |
MOD_PKA_2 | 322 | 328 | PF00069 | 0.502 |
MOD_PKA_2 | 92 | 98 | PF00069 | 0.362 |
MOD_Plk_1 | 265 | 271 | PF00069 | 0.395 |
MOD_Plk_2-3 | 185 | 191 | PF00069 | 0.484 |
MOD_Plk_4 | 49 | 55 | PF00069 | 0.393 |
MOD_ProDKin_1 | 174 | 180 | PF00069 | 0.730 |
MOD_ProDKin_1 | 253 | 259 | PF00069 | 0.420 |
MOD_ProDKin_1 | 303 | 309 | PF00069 | 0.451 |
TRG_ENDOCYTIC_2 | 201 | 204 | PF00928 | 0.326 |
TRG_ENDOCYTIC_2 | 45 | 48 | PF00928 | 0.342 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5Y0 | Leptomonas seymouri | 32% | 78% |
A0A0N1PDA3 | Leptomonas seymouri | 78% | 100% |
A0A0S4INL4 | Bodo saltans | 37% | 77% |
A0A0S4JAJ5 | Bodo saltans | 61% | 100% |
A0A1X0NQR5 | Trypanosomatidae | 35% | 83% |
A0A1X0P2H5 | Trypanosomatidae | 68% | 100% |
A0A3Q8IH71 | Leishmania donovani | 32% | 77% |
A0A3R7M1X1 | Trypanosoma rangeli | 33% | 90% |
A0A3R7MCA7 | Trypanosoma rangeli | 68% | 100% |
A0A3S7X6N8 | Leishmania donovani | 98% | 100% |
A4H647 | Leishmania braziliensis | 33% | 100% |
A4HLI1 | Leishmania braziliensis | 93% | 100% |
A4HUG7 | Leishmania infantum | 32% | 77% |
A4I8Z1 | Leishmania infantum | 98% | 100% |
D0A4Y9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 65% | 100% |
E9AN65 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 100% |
Q4Q464 | Leishmania major | 97% | 100% |
Q4QHG0 | Leishmania major | 33% | 100% |
V5B205 | Trypanosoma cruzi | 34% | 79% |
V5BLV5 | Trypanosoma cruzi | 68% | 100% |